NaviFUS completes innovative pilot study investigating FUS and re-radiotherapy combination treatment for recurrent glioblastoma tumors

NaviFUS’ research on combining focused ultrasound (FUS) with re-radiotherapy for the treatment of recurrent glioblatoma (rGBM) tumors has shown quite some promise in its recent clinical trial, and both the preliminary clinical results and previous preclinical data have been published in the Journal of Neuro-Oncology (https://link.springer.com/article/10.1007/s11060-023-04517-x). ‘

The combined treatment has shown improvement in survival rates and helped stabilize conditions in some rGBM patients through the innovative treatment mechanism of radio-sensitizing (making more susceptible to radiotherapy) the tumor microenvironment. NaviFUS also plans to further investigate whether this treatment can be extended to other kinds of brain tumors like metastatic brain cancers and its corresponding effectiveness in such cases.

View source version on： 放療合併聚焦超音波治腦癌初見療效，浩宇生醫創新研發登國際期刊